Trademark: 97446452
Word
LEGEND BIOTECH
Status
Registered
Status Code
700
Status Date
Tuesday, January 23, 2024
Serial Number
97446452
Registration Number
7283305
Registration Date
Tuesday, January 23, 2024
Mark Type
3000
Filing Date
Tuesday, June 7, 2022
Published for Opposition
Tuesday, November 7, 2023

Trademark Owner History
Nanjing Legend Biotech Co., Ltd. - Original Registrant

Classifications
5 Pharmaceuticals and medical preparations for autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; sanitary preparations for medical purposes; dietetic food and substances adapted for medical use; biological preparations for medical purposes, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; biological tissue cultures for medical purposes; chemical preparations for medical purposes, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; chemical preparations for pharmaceutical purposes, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; drugs for medical purposes, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; immunostimulants; medicines for human purposes, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; pharmaceutical preparations, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; Pharmaceutical compositions for autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; pharmaceuticals for autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; stem cells for medical purposes; Injectable pharmaceuticals for autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; anti-cancer drugs; Anti-cancer preparations; Compounds for treating cancer; Pharmaceutical preparations and substances for the treatment of cancer; Anti-cancer preparations from hormones and antagonists; Biopharmaceuticals for the treatment of cancer; Biological preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer; Cell growth media for growing cells for medical use; Cells for medical use, Living cells for medical use; vaccine preparation; Medical diagnostic preparations
44 Medical services; alternative medicine services; cultured cell bank services for medical transplantation; health care; health centre services; health counselling; health assessment services; hospital services; medical advice for individuals with disabilities; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical assistance; medical clinic services; medical treatment using cultured cells; preparation of prescriptions by pharmacists; therapy services, namely, immunotherapy, cell therapy, gene therapy, antibody therapy, radiation therapy, or chemotherapy; Medical services relating to the removal, treatment and processing of human cells; Providing cancer screening services; Medical services for the treatment of cancer; Medical analysis services for the diagnosis of cancer; Medical analysis services for cancer diagnosis and prognosis; Medical screening; provision of medical information; stem cell therapy services
42 Scientific and technological services, namely, scientific research, analysis, and testing in the field of biotechnology and scientific research and design relating thereto; design and development of computer hardware and software; biological research; chemical analysis; chemical research; chemistry services namely research in the field of chemistry; Scientific research in the nature of conducting clinical trials for others; culturing of cells for scientific research purposes, for others; medical research; research and development of new products for others; scientific laboratory services; scientific research; technological research in the field of biotechnology; Cell separation technology research services; Cell separation research services; Cell culture services for scientific and research purposes, for others; Scientific services relating to the isolation and cultivation of human tissues and cells for scientific and research purposes; Scientific research for medical purposes in the area of cancerous diseases; Stem cell research services; Antibody research and development; Pharmaceutical research and development; Medical computer programming
The mark consists of the wording "LEGEND" above the wording "BIOTECH," both in stylized form and to the right of a wavy line forming the letters "L" and "B".
Color is not claimed as a feature of the mark.
"BIOTECH"

Trademark Events
Jan 23, 2024
Notice Of Registration Confirmation Emailed
Jan 23, 2024
Registered-Principal Register
Nov 7, 2023
Official Gazette Publication Confirmation E-Mailed
Nov 7, 2023
Published For Opposition
Oct 18, 2023
Notification Of Notice Of Publication E-Mailed
Oct 5, 2023
Approved For Pub - Principal Register
Sep 30, 2023
Teas/Email Correspondence Entered
Sep 29, 2023
Correspondence Received In Law Office
Sep 29, 2023
Teas Response To Office Action Received
Sep 25, 2023
Teas Change Of Correspondence Received
Sep 25, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 25, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 25, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 25, 2023
Teas Change Of Owner Address Received
Jun 20, 2023
Application Extension Granted/Receipt Provided
Jun 20, 2023
Application Extension To Response Period - Received
Mar 29, 2023
Notification Of Non-Final Action E-Mailed
Mar 29, 2023
Non-Final Action E-Mailed
Mar 29, 2023
Non-Final Action Written
Mar 22, 2023
Assigned To Examiner
Jun 17, 2022
Notice Of Design Search Code E-Mailed
Jun 16, 2022
New Application Office Supplied Data Entered
Jun 10, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24